Homo sapiens Protein: RUNX2 | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||
InnateDB Protein | IDBP-89687.6 | ||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||
Gene Symbol | RUNX2 | ||||||||||||||||||||||
Protein Name | runt-related transcription factor 2 | ||||||||||||||||||||||
Synonyms | AML3; CBF-alpha-1; CBFA1; CCD; CCD1; CLCD; OSF-2; OSF2; PEA2aA; PEBP2aA; | ||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||
Ensembl Protein | ENSP00000352514 | ||||||||||||||||||||||
InnateDB Gene | IDBG-89685 (RUNX2) | ||||||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||
Function | Transcription factor involved in osteoblastic differentiation and skeletal morphogenesis. Essential for the maturation of osteoblasts and both intramembranous and endochondral ossification. CBF binds to the core site, 5'- PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, osteocalcin, osteopontin, bone sialoprotein, alpha 1(I) collagen, LCK, IL-3 and GM-CSF promoters. In osteoblasts, supports transcription activation: synergizes with SPEN/MINT to enhance FGFR2-mediated activation of the osteocalcin FGF-responsive element (OCFRE) (By similarity). Inhibits KAT6B-dependent transcriptional activation. {ECO:0000250, ECO:0000269PubMed:11965546}. | ||||||||||||||||||||||
Subcellular Localization | Nucleus. | ||||||||||||||||||||||
Disease Associations | Cleidocranial dysplasia (CLCD) [MIM:119600]: Autosomal dominant skeletal disorder with high penetrance and variable expressivity. It is due to defective endochondral and intramembranous bone formation. Typical features include hypoplasia/aplasia of clavicles, patent fontanelles, wormian bones (additional cranial plates caused by abnormal ossification of the calvaria), supernumerary teeth, short stature, and other skeletal changes. In some cases defects in RUNX2 are exclusively associated with dental anomalies. {ECO:0000269PubMed:10521292, ECO:0000269PubMed:10545612, ECO:0000269PubMed:10689183, ECO:0000269PubMed:10980549, ECO:0000269PubMed:11857736, ECO:0000269PubMed:12081718, ECO:0000269PubMed:12196916, ECO:0000269PubMed:12424590, ECO:0000269PubMed:16270353, ECO:0000269PubMed:19744171, ECO:0000269PubMed:20082269, ECO:0000269PubMed:20648631, ECO:0000269PubMed:9182765, ECO:0000269PubMed:9207800}. Note=The disease is caused by mutations affecting the gene represented in this entry.Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly (MDMHB) [MIM:156510]: An autosomal dominant bone dysplasia characterized by metaphyseal flaring of long bones, enlargement of the medial halves of the clavicles, maxillary hypoplasia, variable brachydactyly, and dystrophic teeth. {ECO:0000269PubMed:23290074}. Note=The disease is caused by mutations affecting the gene represented in this entry. Analysis for copy-number variations revealed that a 105 kb duplication within RUNX2 segregated with the MDMHB phenotype in a region with maximum linkage. Real-time PCR for copy-number variation in genomic DNA in eight samples, as well as sequence analysis of fibroblast cDNA from one subject with MDMHB confirmed that affected family members were heterozygous for the presence of an intragenic duplication encompassing exons 3 to 5 of RUNX2. These three exons code for the Q/A domain and the functionally essential DNA-binding Runt domain of RUNX2. The RUNX2 duplication found in individuals with MDMHB leads to a gain of function (PubMed:23290074). {ECO:0000269PubMed:23290074}. | ||||||||||||||||||||||
Tissue Specificity | Specifically expressed in osteoblasts. | ||||||||||||||||||||||
Comments | |||||||||||||||||||||||
Interactions | |||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 74 experimentally validated interaction(s) in this database.
They are also associated with 17 interaction(s) predicted by orthology.
|
||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||
InterPro |
IPR000040
Acute myeloid leukemia 1 protein (AML1)/Runt IPR008967 p53-like transcription factor, DNA-binding IPR013524 Runt domain IPR013711 Runx, C-terminal domain IPR016554 Runt-related transcription factor RUNX |
||||||||||||||||||||||
PFAM |
PF00853
PF08504 |
||||||||||||||||||||||
PRINTS |
PR00967
|
||||||||||||||||||||||
PIRSF |
PIRSF009374
|
||||||||||||||||||||||
SMART | |||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||
Modification | |||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||
SwissProt | Q13950 | ||||||||||||||||||||||
PhosphoSite | PhosphoSite-Q13950 | ||||||||||||||||||||||
TrEMBL | U3RG86 | ||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||
Entrez Gene | 860 | ||||||||||||||||||||||
UniGene | Hs.717834 | ||||||||||||||||||||||
RefSeq | NP_001265407 | ||||||||||||||||||||||
HUGO | HGNC:10472 | ||||||||||||||||||||||
OMIM | 600211 | ||||||||||||||||||||||
CCDS | |||||||||||||||||||||||
HPRD | 02566 | ||||||||||||||||||||||
IMGT | |||||||||||||||||||||||
EMBL | AF001443 AF001444 AF001445 AF001446 AF001447 AF001448 AF001449 AF001450 AF053949 AF053952 AL096865 AL161907 AL358135 BC108919 BC108920 KF279692 L40992 | ||||||||||||||||||||||
GenPept | AAA89072 AAB65158 AAB65159 AAC77441 AAC78624 AAI08920 AAI08921 AGW99946 CAI13528 CAI13531 CAI19638 CAI19639 CAI19925 CAI19931 | ||||||||||||||||||||||